Literature DB >> 21401874

Risk of window period hepatitis-C infection in high infectious risk donors: systematic review and meta-analysis.

L M Kucirka1, H Sarathy, P Govindan, J H Wolf, T A Ellison, L J Hart, R A Montgomery, R L Ros, D L Segev.   

Abstract

The OPTN classifies high infectious risk donors (HRDs) based on criteria originally intended to identify people at risk for HIV infection. These donors are sometimes referred to as 'CDC high risk donors' in reference to the CDC-published guidelines adopted by the OPTN. However, these guidelines are also being used to identify deceased donors at increased risk of window period (WP) hepatitis C virus (HCV) infection, although not designed for this purpose. The actual risk of WP HCV infection in HRDs is unknown. We performed a systematic review of 3476 abstracts and identified 37 eligible estimates of HCV incidence in HRD populations in the United States/Canada. Pooled HCV incidence was derived and used to estimate the risk of WP infection for each HRD category. Risks ranged from 0.26 to 300.6 per 10,000 donors based on WP for ELISA and 0.027 to 32.4 based on nucleic acid testing (NAT). Injection drug users were at highest risk (32.4 per 10,000 donors by NAT WP), followed by commercial sex workers and donors exhibiting high risk sexual behavior (12.3 per 10,000), men who have sex with men (3.5 per 10,000), incarcerated donors (0.8 per 10,000), donors exposed to HIV infected blood (0.4 per 10,000) and hemophiliacs (0.027 per 10,000). NAT reduced WP risk by approximately 10-fold in each category. ©2011 The Authors Journal compilation©2011 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Mesh:

Year:  2011        PMID: 21401874      PMCID: PMC3110646          DOI: 10.1111/j.1600-6143.2011.03460.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  73 in total

1.  Viral nucleic acid testing (NAT) and OPO-level disposition of high-risk donor organs.

Authors:  L M Kucirka; C Alexander; R Namuyinga; C Hanrahan; R A Montgomery; D L Segev
Journal:  Am J Transplant       Date:  2009-02-03       Impact factor: 8.086

2.  Seroprevalence and risk factors of hepatitis B, hepatitis C, and human cytomegalovirus among HIV-infected and high-risk uninfected adolescents: findings of the REACH Study. Adolescent Medicine HIV/AIDS Research Network.

Authors:  C A Holland; Y Ma; B Moscicki; S J Durako; L Levin; C M Wilson
Journal:  Sex Transm Dis       Date:  2000-05       Impact factor: 2.830

3.  Hepatitis C virus infection in young, low-income women: the role of sexually transmitted infection as a potential cofactor for HCV infection.

Authors:  Kimberly A Page-Shafer; Barbara Cahoon-Young; Jeffrey D Klausner; Scott Morrow; Fred Molitor; Juan Ruiz; Willi McFarland
Journal:  Am J Public Health       Date:  2002-04       Impact factor: 9.308

4.  Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection.

Authors:  D M Patrick; M W Tyndall; P G Cornelisse; K Li; C H Sherlock; M L Rekart; S A Strathdee; S L Currie; M T Schechter; M V O'Shaughnessy
Journal:  CMAJ       Date:  2001-10-02       Impact factor: 8.262

5.  Hepatitis C prevalence and risk factors in the northern Alberta dialysis population.

Authors:  J Sandhu; J K Preiksaitis; P M Campbell; K C Carriere; P A Hessel
Journal:  Am J Epidemiol       Date:  1999-07-01       Impact factor: 4.897

6.  Prevalence of and risk factors for hepatitis C virus infection among STD clinic clientele in Miami, Florida.

Authors:  J S Weisbord; M J Trepka; G Zhang; I P Smith; T Brewer
Journal:  Sex Transm Infect       Date:  2003-02       Impact factor: 3.519

7.  HIV and HCV prevalence and gender-specific risk profiles of crack cocaine smokers and dual users of injection drugs.

Authors:  Kate Shannon; Melanie Rusch; Robert Morgan; Megan Oleson; Thomas Kerr; Mark W Tyndall
Journal:  Subst Use Misuse       Date:  2008       Impact factor: 2.164

8.  The Cedar project: prevalence and correlates of HIV infection among young Aboriginal people who use drugs in two Canadian cities.

Authors:  Patricia M Spittal; Kevin J P Craib; Mary Teegee; Catherine Baylis; Wayne M Christian; A K M Moniruzzaman; Martin T Schechter
Journal:  Int J Circumpolar Health       Date:  2007-06       Impact factor: 1.228

9.  Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2004.

Authors:  Joseph J Amon; Richard S Garfein; Linda Ahdieh-Grant; Gregory L Armstrong; Lawrence J Ouellet; Mary H Latka; David Vlahov; Steffanie A Strathdee; Sharon M Hudson; Peter Kerndt; Don Des Jarlais; Ian T Williams
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

10.  Incident hepatitis C virus in women with human immunodeficiency virus infection.

Authors:  M Augenbraun; J J Goedert; D Thomas; J Feldman; E C Seaberg; A L French; E Robison; M Nowicki; N Terrault
Journal:  Clin Infect Dis       Date:  2003-10-14       Impact factor: 9.079

View more
  42 in total

Review 1.  New Solutions to Reduce Discard of Kidneys Donated for Transplantation.

Authors:  Peter P Reese; Meera N Harhay; Peter L Abt; Matthew H Levine; Scott D Halpern
Journal:  J Am Soc Nephrol       Date:  2015-09-14       Impact factor: 10.121

2.  Outcomes After Declining Increased Infectious Risk Kidney Offers for Pediatric Candidates in the United States.

Authors:  Mary G Bowring; Kyle R Jackson; Heather Wasik; Alicia Neu; Jacqueline Garonzik-Wang; Christine Durand; Niraj Desai; Allan B Massie; Dorry L Segev
Journal:  Transplantation       Date:  2019-12       Impact factor: 4.939

3.  Prevalence of antibodies to hepatitis C virus in voluntary blood donors: are women better donors?

Authors:  Dakshayani Padmakar Pandit; Pradhan Pagaro M; Chaudhury Nabamita
Journal:  J Clin Diagn Res       Date:  2014-04-15

4.  Rates of HIV, syphilis, and HCV infections among different demographic groups of female sex workers in Guangxi China: evidence from 2010 national sentinel surveillance data.

Authors:  Yuejiao Zhou; Xiaoming Li; Chen Zhang; Guangjie Tan; Bonita Stanton; Xiaojuan Zhang; Yan Cui
Journal:  AIDS Care       Date:  2013-02-25

Review 5.  Towards pathogen inactivation of red blood cells and whole blood targeting viral DNA/RNA: design, technologies, and future prospects for developing countries.

Authors:  Victor J Drew; Lassina Barro; Jerard Seghatchian; Thierry Burnouf
Journal:  Blood Transfus       Date:  2017-04-13       Impact factor: 3.443

6.  Guidelines for the assessment and acceptance of potential brain-dead organ donors.

Authors:  Glauco Adrieno Westphal; Valter Duro Garcia; Rafael Lisboa de Souza; Cristiano Augusto Franke; Kalinca Daberkow Vieira; Viviane Renata Zaclikevis Birckholz; Miriam Cristine Machado; Eliana Régia Barbosa de Almeida; Fernando Osni Machado; Luiz Antônio da Costa Sardinha; Raquel Wanzuita; Carlos Eduardo Soares Silvado; Gerson Costa; Vera Braatz; Milton Caldeira Filho; Rodrigo Furtado; Luana Alves Tannous; André Gustavo Neves de Albuquerque; Edson Abdala
Journal:  Rev Bras Ter Intensiva       Date:  2016-09

7.  Virus NAT for HIV, HBV, and HCV in Post-Mortal Blood Specimens over 48 h after Death of Infected Patients - First Results.

Authors:  Thomas Meyer; Susanne Polywka; Birgit Wulff; Carolin Edler; Ann Sophie Schröder; Ina Wilkemeyer; Ulrich Kalus; Axel Pruss
Journal:  Transfus Med Hemother       Date:  2012-11-19       Impact factor: 3.747

8.  Kidney allograft offers: Predictors of turndown and the impact of late organ acceptance on allograft survival.

Authors:  J B Cohen; J Shults; D S Goldberg; P L Abt; D L Sawinski; P P Reese
Journal:  Am J Transplant       Date:  2017-09-02       Impact factor: 8.086

9.  Turn down for what? Patient outcomes associated with declining increased infectious risk kidneys.

Authors:  Mary G Bowring; Courtenay M Holscher; Sheng Zhou; Allan B Massie; Jacqueline Garonzik-Wang; Lauren M Kucirka; Sommer E Gentry; Dorry L Segev
Journal:  Am J Transplant       Date:  2017-12-05       Impact factor: 8.086

10.  Donor-derived infection: epidemiology and outcomes.

Authors:  Daniel R Kaul
Journal:  Curr Infect Dis Rep       Date:  2012-12       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.